Deletion of Intestinal SHP Impairs Short-term Response to Cholic Acid Challenge in Male Mice.


Journal

Endocrinology
ISSN: 1945-7170
Titre abrégé: Endocrinology
Pays: United States
ID NLM: 0375040

Informations de publication

Date de publication:
01 08 2021
Historique:
received: 09 09 2020
pubmed: 27 3 2021
medline: 21 10 2021
entrez: 26 3 2021
Statut: ppublish

Résumé

Small heterodimer partner (SHP) is a crucial regulator of bile acid (BA) transport and synthesis; however, its intestine-specific role is not fully understood. Here, we report that male intestine-specific Shp knockout (IShpKO) mice exhibit higher intestinal BA but not hepatic or serum BA levels compared with the f/f Shp animals when challenged with an acute (5-day) 1% cholic acid (CA) diet. We also found that BA synthetic genes Cyp7a1 and Cyp8b1 are not repressed to the same extent in IShpKO compared with control mice post-CA challenge. Loss of intestinal SHP did not alter Fxrα messenger RNA (mRNA) but increased Asbt (BA ileal uptake transporter) and Ostα (BA ileal efflux transporter) expression even under chow-fed conditions. Surprisingly, the acute CA diet in IShpKO did not elicit the expected induction of Fgf15 but was able to maintain the suppression of Asbt, and Ostα/β mRNA levels. At the protein level, apical sodium-dependent bile acid transporter (ASBT) was downregulated, while organic solute transporter-α/β (OSTα/β) expression was induced and maintained regardless of diet. Examination of ileal histology in IShpKO mice challenged with acute CA diet revealed reduced villi length and goblet cell numbers. However, no difference in villi length, and the expression of BA regulator and transporter genes, was seen between f/f Shp and IShpKO animals after a chronic (14-day) CA diet, suggesting a potential adaptive response. We found the upregulation of the Pparα-Ugt axis after 14 days of CA diet may reduce the BA burden and compensate for the ileal SHP function. Thus, our study reveals that ileal SHP expression contributes to both overall intestinal structure and BA homeostasis.

Identifiants

pubmed: 33769482
pii: 6189092
doi: 10.1210/endocr/bqab063
pmc: PMC8256632
pii:
doi:

Substances chimiques

Carrier Proteins 0
Membrane Glycoproteins 0
PPAR alpha 0
Receptors, Cytoplasmic and Nuclear 0
bile acid binding proteins 0
fibroblast growth factor 15, mouse 0
nuclear receptor subfamily 0, group B, member 2 0
Fibroblast Growth Factors 62031-54-3
Cholic Acid G1JO7801AE

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK113080
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Nat Commun. 2014 Sep 03;5:4573
pubmed: 25183423
J Lipid Res. 2015 Jun;56(6):1085-99
pubmed: 25210150
J Biol Chem. 2003 May 30;278(22):19909-16
pubmed: 12456679
Circ Res. 2014 Aug 15;115(5):493-503
pubmed: 25015078
Drug Metab Rev. 2013 Feb;45(1):145-55
pubmed: 23330546
Curr Opin Lipidol. 2016 Jun;27(3):295-301
pubmed: 27031274
Hepatology. 2004 Jul;40(1):149-56
pubmed: 15239098
J Lipid Res. 2009 Apr;50 Suppl:S120-5
pubmed: 18815433
J Biol Chem. 2012 Jun 15;287(25):21233-43
pubmed: 22535958
J Biol Chem. 2002 Aug 23;277(34):30559-66
pubmed: 12055195
Hepatology. 2011 Mar;53(3):996-1006
pubmed: 21319191
Endocrinology. 2021 Aug 1;162(8):
pubmed: 33769482
Mol Cell. 2000 Sep;6(3):507-15
pubmed: 11030331
Dig Dis. 2011;29(1):18-22
pubmed: 21691100
Mol Endocrinol. 2008 Jun;22(6):1345-56
pubmed: 18323469
J Lipid Res. 2007 Dec;48(12):2664-72
pubmed: 17720959
Mol Aspects Med. 2013 Apr-Jun;34(2-3):683-92
pubmed: 23506901
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3891-6
pubmed: 18292224
Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G912-22
pubmed: 16357058
Compr Physiol. 2012 Oct;2(4):2811-28
pubmed: 23720266
J Lipid Res. 2009 Aug;50(8):1509-20
pubmed: 19346331
Nat Rev Genet. 2001 Oct;2(10):743-55
pubmed: 11584291
Cell Mol Gastroenterol Hepatol. 2017 Jan 24;3(3):422-446
pubmed: 28462382
Biosci Biotechnol Biochem. 2014;78(9):1584-91
pubmed: 25209508
Cell Metab. 2005 Oct;2(4):217-25
pubmed: 16213224
Biochem J. 2007 Nov 1;407(3):363-72
pubmed: 17650074
Nat Rev Endocrinol. 2014 Aug;10(8):488-98
pubmed: 24821328
Liver Int. 2015 Apr;35(4):1133-1144
pubmed: 25156247
Front Biosci (Landmark Ed). 2009 Jan 01;14(8):2829-44
pubmed: 19273238
Ann Gastroenterol. 2018 May-Jun;31(3):266-272
pubmed: 29720851
J Biol Chem. 2000 Sep 15;275(37):28947-53
pubmed: 10867000
Nucl Receptor Res. 2015;2:
pubmed: 26504773
Dev Cell. 2002 Jun;2(6):721-31
pubmed: 12062085
Dig Dis. 2015;33(3):327-31
pubmed: 26045265
Gastroenterology. 2019 Mar;156(4):1052-1065
pubmed: 30521806
Biochim Biophys Acta. 2011 Aug;1812(8):893-908
pubmed: 20970497
J Biol Chem. 2002 Sep 6;277(36):33275-83
pubmed: 12065599
Am J Physiol Gastrointest Liver Physiol. 2012 Jan 1;302(1):G123-33
pubmed: 22016432
J Hepatol. 2013 Jan;58(1):155-68
pubmed: 22885388
Poult Sci. 2006 Sep;85(9):1535-40
pubmed: 16977838
Cell Res. 2018 Aug;28(8):803-818
pubmed: 29844583
Mol Omics. 2020 Feb 17;16(1):39-58
pubmed: 31819932
World J Diabetes. 2016 Jul 10;7(13):260-70
pubmed: 27433295
Histochem Cell Biol. 2016 Aug;146(2):141-52
pubmed: 27145961
Nat Commun. 2018 Feb 7;9(1):540
pubmed: 29416063
J Biol Chem. 2013 Aug 9;288(32):23252-63
pubmed: 23824184
J Exp Med. 2018 Feb 5;215(2):383-396
pubmed: 29339445
J Lipid Res. 2002 Apr;43(4):533-43
pubmed: 11907135
Am J Physiol Gastrointest Liver Physiol. 2005 Jan;288(1):G60-6
pubmed: 15591588
Gut. 2004 Jan;53(1):78-84
pubmed: 14684580
Sci Adv. 2021 Apr 21;7(17):
pubmed: 33883138
Trends Endocrinol Metab. 2005 Dec;16(10):478-88
pubmed: 16275121
Nat Commun. 2016 Jul 14;7:12179
pubmed: 27412403
J Biol Chem. 2003 Dec 12;278(50):50047-52
pubmed: 14522988
J Lipids. 2012;2012:304292
pubmed: 22577560
J Clin Invest. 2011 Jan;121(1):86-95
pubmed: 21123943
Mol Cell. 2000 Sep;6(3):517-26
pubmed: 11030332
Physiol Rev. 2018 Oct 1;98(4):1983-2023
pubmed: 30067158

Auteurs

James T Nguyen (JT)

Department of Molecular & Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.

Ryan Riessen (R)

Department of Molecular & Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.

Tongyu Zhang (T)

Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.

Collin Kieffer (C)

Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.

Sayeepriyadarshini Anakk (S)

Department of Molecular & Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH